Insulin and heart failure S. H. Taylor' Insulin and glucose have long been known to be effective in experimental heart failure but there is still surprisingly little knowledge of their effects on cardiac function in man. Reawakening of interest in this relation has been occasioned by two recent findings. Firstly, the critical role of glucose in the metabolism of the failing anoxic heart has been precisely defined (Scheuer, I967; Weissler et al., I968; Owen, Thomas, and Opie, I969) . Secondly, the finding that insulin release was suppressed in patients in heart failure (Taylor et Role of glucose and insulin in the metabolism of the failing heart Cardiac muscle uses a variety of substrates for the production of energy, the most important of which are free fatty acids, lactate, pyruvate, and glucose. Under normal physiological conditions fatty acids provide by far the major source of energy, lactate, pyruvate, and glucose supplying only a small part of the normal energy requirement of the heart. Though the heart is able to store small amounts of both lipid and glycogen, the major part of the energy requirements of the heart is run on a current account.
The transport mechanisms by which these various substrates enter the myocardial cell appear to be qualitatively similar to those present in other tissues. Lipids are first hydrolysed in the interstitial space before transport into the cell; the entry ofglucose into the myocardial cell is insulin dependent.
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I acids, lactate, pyruvate, and glucose are metabolized to produce the high-energy adenosine-triphosphate. The myocardial cell differs conspicuously from other muscle cells in that the final step in this process in the heart is critically oxygen dependent. The emphasis on oxidative metabolism in the myocardial cell is reflected in the fact that any reduction in its oxygen tension immediately results in conspicuous changes in electrical activity and contractile performance of the heart (Tennant and Wiggers, I935; Sayen et al., I954) . Thus, the normally efficient metabolism of fatty acids and pyruvate is seriously retarded by hypoxic conditions and under these conditions the anaerobic metabolism of glucose, the only alternative source of energy, is selectively increased. In fact, the extent of the survival of the hypoxic heart is directly dependent on its ability to increase its utilization of glucose (Cascarano, Chick, and Seidman, I968; Weissler et al., I968) . The survival of the anoxic failing heart is therefore directly related to the availability of glucose to the myocardial cell, which in turn is directly dependent upon the transport facility offered by insulin. Thus, glucose and insulin together play a vital role in maintaining the emergency mechanisms of energy production in the failing hypoxic heart.
Secretion of insulin in heart failure The onset of heart failure, particularly left ventricular failure, is immediately associated with reflex circulatory changes which maintain cerebral blood flow by sustaining the blood pressure. These primary circulatory adaptations are brought about by an increase in sympathetic nervous activity, which results in increased pumping activity of the heart accompanied by a reduction in flow to the majority of the regional vascular territories due to vasoconstriction. This intense sympathetic activity is accompanied by an increased liberation of catecholamines, both from the sympathetic nerve endings and from the adrenal medulla (Chidsey, Braunwald, and Morrow, I965 (Loubatieres et al., I965) . Adrenergic alphastimulation and beta-blockade both suppress insulin release in normal man while alphablockade and beta-stimulation both potentiate insulin release (Majid et al., 1970) . These observations show that the sympathetic nervous system has an important role in the control of insulin secretion. In heart failure, where sympathetic nervous activity may be intense, this powerful influence may result in suppression of insulin release even in the presence of hyperglycaemia, the normal stimulus to insulin secretion. The evidence suggests that this suppression of insulin release is due to the direct effects of sympathetically mediated vasoconstriction of the pancreas potentiated by the increased levels of circulating catecholamines.
The potential therapeutic importance of these arguments has recently been demonstrated by their application to the treatment of patients in severe heart failure (Majid et al., I970) . Insulin suppression in these patients was immediately relieved by alpha-blockade with phentolamine and by beta-stimulation with isoprenaline and the effect of the two drugs together was summative. In the past, the use of these two agents in patients with a low cardiac output state has been largely concerned with their direct haemodvnamic effects, but these recent observations suggest that they may play an additional and vital role in the metabolic support of the failing heart by release of the associated insulin suppression.
group.bmj.com on June 22, 2017 -Published by http://heart.bmj.com/ Downloaded from Treatment of heart failure with insulin and glucose The interrelation between insulin activity, glucose consumption, and energy production by the heart came into prominence at the beginning of this century after the discovery by Knowlton and Starling (1912) that the addition of pancreatic extract increased the sugar consumption of the heart in diabetic dogs and cats to normal. Later, Clark (I9I6) showed that this increased use of sugar by the heart was directly related to the development of additional contractile energy; Hepburn and Latchford (I922) also showed that the addition of insulin to the perfusate through the isolated rabbit heart tripled its sugar consumption. In the light of recent metabolic studies, Burn and Dale (1924) made the important observation that the addition of insulin to the isolated heart accelerated the removal of glucose without change in its respiratory quotient of unity, and Visscher and Muller (I927) concluded that insulin resulted in an increase in myocardial contractility which was independent of processes involving oxidative metabolism. The potential therapeutic significance of these findings was directly confirmed by Bayliss, Muller, and Starling (I928) who observed that the addition of insulin and glucose to the isolated perfused heart postponed the onset of failure, and by Gremels (1940) who noticed that heart failure in the isolated heart-lung preparation was invariably preceded by a decrease in glucose utilization by the heart. In view of these and other more recent demonstrations that the failing heart is glucose dependent, and that the therapeutic efficiency of the digitalis glycosides are also dependent on glucose transport (Berman, Masuoka, and Saunders, I957) , it is remarkable that so little clinical attention has been paid to these potentially important therapeutic observations. A number of early reports claimed to have shown clinical benefit in patients in heart failure from the use of oral or intravenous glucose, and some noted the disappearance of electrical alternation during such treatment. However, it is possible that the large amounts of glucose given in these early studies may have achieved some of their benefit by an induced sugar diuresis, particularly in view of the recent finding of insulin suppression in such patients. Contemporary interest in the use of insulin and glucose in heart disease has been nearly entirely directed towards their effects in myocardial infarction. Early reports were concerned with the effects of insulin and glucose treatment on survival after resuscitation from cardiac arrest subsequent to acute myocardial infarction; significant benefits were claimed (Laborit, I963) . More recent attention has been devoted to the prevention and correction of cardiac dysrhythmias after myocardial infarction (Sodi-Pallares et al., I962; Lundman and Orinius, I965; Mittra, I965). Though insulin has been shown to be essential for glucose utilization and the maintenance of a normal intracellular potassium concentration, the results of studies of the prophylactic benefit of insulin and glucose against dysrhythmias developing after myocardial infarction have been therapeutically disappointing. Though many reports have claimed that insulin, glucose, and potassium treatment afford significant protection against the development of dysrhythmias after myocardial infarction, a number of more carefully designed studies failed to confirm these findings (Sievers et al., I966; Autio et al., I966; Pilcher et al., I967; Medical Research Council Report, I968) . However, the results of these trials are difficult to interpret due to the different criteria for the selection of patients, different regimens of treatment employed, and the different methods of evaluation of results. The potential value of such treatment must await proof that myocardial cells in an area of infarction are potassium depleted and that the administration of glucose and additional insulin is capable ofrestoration ofthe intracellular potassium of these anoxic fibres. Until such experimental evidence is forthcoming, the place of insulin, glucose, and potassium therapy in the prevention of cardiac dysrhythmias will remain conjectural.
Resum6
The failing anoxic heart is nearly completely dependent upon the metabolism of glucose to maintain its energy requirements. Though this emergency mechanism cannot supply more than a small proportion of the energy required by the normal heart, in heart failure even this small contribution to energy production may suffice to maintain essential contractile function for short periods. The availability of glucose to the myocardial cell is completely dependent upon an adequate supply of insulin. In severe heart failure insulin release is suppressed by the combined effects of low pancreatic blood flow and increased catecholamine secretion. In these circumstances the emergency mechanisms of myocardial metabolism which utilize glucose may break down through lack of insulin. Though it has long been known that insulin and glucose may resuscitate the failing isolated heart, the role of insulin and the control of its secretion in heart failure appears to have been largely neglected despite its potentially important therapeutic significance.
